Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.665
+0.465 (14.53%)
At close: Aug 21, 2026, 4:00 PM EDT
3.660
-0.005 (-0.14%)
After-hours: Aug 21, 2026, 7:14 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $7.06 million as of August 21, 2026. Its market cap has decreased by -24.63% in one year.
Market Cap
7.06M
Enterprise Value
11.09M
1-Year Change
-24.63%
Ranking
Category
Stock Price
$3.67
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $7.06M, a decrease of -98.98%. That is a compound annual growth rate of -56.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 7.06M | -32.73% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 6.68M |
| NuCana | 6.59M |
| Cardio Diagnostics Holdings | 6.54M |
| Purple Biotech | 6.25M |
| Evogene | 6.24M |
| Addex Therapeutics | 6.18M |
| Ensysce Biosciences | 6.13M |
| CollPlant Biotechnologies | 6.01M |